| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.600 | None | 0.914 | 9 | 0 | 1994 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.600 | None | 0.990 | 8 | 0 | 1996 | 2019 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.300 | None | 0.974 | 7 | 0 | 1998 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.976 | 6 | 0 | 1999 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.300 | None | 1.000 | 5 | 0 | 1999 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.100 | None | 0.967 | 5 | 0 | 1999 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.960 | 5 | 0 | 2003 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.100 | None | 0.929 | 4 | 0 | 1996 | 2019 | ||||||||
|
carnosine dipeptidase 1 | 0.656 | 0.538 | 1.2E-09 |
|
disease | 0.400 | None | 0.929 | 4 | 0 | 2005 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.600 | None | 0.962 | 4 | 0 | 2003 | 2019 | ||||||||
|
NPHS1 adhesion molecule, nephrin | 0.597 | 0.615 | 2.5E-14 |
|
disease | 0.050 | None | 0.800 | 3 | 0 | 2002 | 2009 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.100 | None | 0.971 | 3 | 0 | 1997 | 2019 | ||||||||
|
solute carrier family 12 member 3 | 0.493 | 0.808 | 3.0E-32 |
|
disease | 0.090 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.498 | 0.808 | 5.0E-08 |
|
disease | 0.080 | None | 1.000 | 3 | 0 | 2002 | 2015 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
disease | 0.270 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2007 | ||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 2 | 0 | 2005 | 2016 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | ||||||||
|
engulfment and cell motility 1 | 0.608 | 0.615 | 0.90 |
|
disease | 0.400 | None | 0.933 | 2 | 0 | 2005 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.600 | None | 0.941 | 2 | 0 | 2000 | 2019 | ||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2004 | 2015 | ||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
disease | 0.060 | None | 0.833 | 2 | 0 | 2008 | 2018 | ||||||||
|
transforming growth factor beta induced | 0.484 | 0.769 | 6.0E-08 |
|
disease | 0.530 | None | 1.000 | 2 | 0 | 2003 | 2012 | ||||||||
|
small ubiquitin like modifier 4 | 0.653 | 0.577 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2007 | 2016 |